Investigating the effect of variable interferon signaling on CD4+ t cells

Active Project Grant Awarded Last action

Award ID
F31AI203423
Recipient
Awarding agency
Obligated
$50,114

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 0% complete
Place of performance
New York, NY 10016, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Inflammation underlies all immune responses, but IT is a double-edged sword: too little impairs danger sensing, lymphocyte function, and memory formation, while too much drives cytotoxicity and immunopathology. Understanding its consequences is essential for optimizing immunity during infection, vaccination, and aging. My project examines how priming in an inflamed environment shapes lymphocyte differentiation, focusing on the effect of type i interferon (IFN-i) on CD4⁺ memory t cells. IFN-i is broadly induced during viral infection and is known to durably imprint interferon-related programs in memory b cells, yet its influence on CD4⁺ t cell memory differentiation is unclear. Defining how elevated inflammation affects CD4⁺ t cell differentiation and antibody production may reveal avenues to improve vaccine efficacy. Our lab has shown that memory CD4⁺ t cells retain distinct transcriptional signatures depending on whether their initial exposure was to sars-COV-2 vaccination or infection, with inflammation-primed cells enriched for IFN-i-related genes. Because IFN-i and broader inflammatory signals are stronger during infection than vaccination, we ask whether the magnitude of IFN-i signaling influences CD4⁺ t cell memory differentiation. I hypothesize that IFN-i modifies CD4⁺ t memory differentiation and function upon secondary infection. I will test this hypothesis using a novel mouse system with variable IFN-i signaling that includes both an established mutant with enhanced IFN-i activity and a new mouse line i generated with attenuated signaling. By immunizing and infecting these mice, i will assess how tunable IFN-i responses shape CD4⁺ t cell memory differentiation and function during primary and secondary immune responses. This work uses a unique model system to define how IFN-i signaling programs CD4⁺ memory t cells and influences their recall responses, providing insights that are essential for understanding adaptive immunity and for guiding the development of effective long lasting vaccines.

Quick answers

Who received award F31AI203423?

F31AI203423 was awarded to New York University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 25, 2027.

How much is award F31AI203423 worth?

$50,114 has been obligated on F31AI203423.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login